AUTHOR OF THIS BLOG

DR ANTHONY MELVIN CRASTO, WORLDDRUGTRACKER

Discovery of Unexpectedly Active Group-Introduction of a sulfoximine group into anticancer candidates shows that sometimes sticking to the unconventional pays off

 Uncategorized  Comments Off on Discovery of Unexpectedly Active Group-Introduction of a sulfoximine group into anticancer candidates shows that sometimes sticking to the unconventional pays off
May 312013
 

thumbnail image: Discovery of Unexpectedly Active Group

Introduction of a sulfoximine group into anticancer candidates shows that sometimes sticking to the unconventional pays off

Read more

Share

A Drug Discovery Detective Story-Biological activity of small-molecule RNA polymerase (RNAP) inhibitors revealed to come from polymeric impurity

 Uncategorized  Comments Off on A Drug Discovery Detective Story-Biological activity of small-molecule RNA polymerase (RNAP) inhibitors revealed to come from polymeric impurity
May 312013
 

thumbnail image: A Drug Discovery Detective Story

Biological activity of small-molecule RNA polymerase (RNAP) inhibitors revealed to come from polymeric impurity

Read more

Share

Researchers identify novel class of drugs for prostate cancers

 Uncategorized  Comments Off on Researchers identify novel class of drugs for prostate cancers
May 292013
 

Photo of Dr. Ganesh Raj, an associate professor of urology at UT Southwestern Medical Center.

http://www.sciencecodex.com/researchers_identify_novel_class_of_drugs_for_prostate_cancers-112935

(Photo Credit: UT Southwestern Medical Center)

Share

Slowing the aging process using only antibiotics

 Uncategorized  1 Response »
May 282013
 

Slowing the aging process -- only with antibiotics

EPFL scientists have revealed the mechanism, hidden deep within cell mitochondria, that is responsible for making organisms age. Nematodes treated with antibiotics designed to disrupt this mechanism lived longer and healthier lives.

(Photo Credit: EPFLnews)

Slowing the aging process using only antibiotics 

 

READ ALL AT

http://www.kurzweilai.net/slowing-the-aging-process-using-only-antibiotics?utm_source=KurzweilAI+Daily+Newsletter&utm_campaign=b2bfdefdba-UA-946742-1&utm_medium=email&utm_term=0_6de721fb33-b2bfdefdba-282116853

Why is it that within a homogeneous population of the same species, some individuals live three times as long as others? EPFL researchers investigated this question and found the mechanism responsible for aging hidden deep within mitochondria. The were able to dramatically slow aging down in worms by administering antibiotics to the young, achieving a … more…
Share

 Permalink  Uncategorized  Comments Off on
May 282013
 

Rituximab (trade names Rituxan and MabThera) is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of B cells. Rituximab destroys B cells, and is therefore used to treat diseases which are characterized by excessive numbers of B cells, overactive B cells, or dysfunctional B cells. This includes many lymphomas, leukemias, transplant rejection, and autoimmune disorders.

Rituxan

Tiny Biotech Developing Drugs Akin To Biogen’s Rituxan Seen As Potential …
Forbes
One small biopharmaceutical that believes it has a proven technology for another blockbuster is TG Therapeutics (TGTX), which is focused on developing drugs for the treatment of cancer and other underserved therapeutic needs, including hematologic …read all

http://www.forbes.com/sites/genemarcial/2013/05/27/tiny-biotech-developing-drugs-akin-to-biogens-rituxan-seen-as-potential-buyout-bet/

Share

CFDA Approves Clinical Trials for Novel China AIDS Treatment, Azi Fu (Azvudine)

 AIDS, Uncategorized  Comments Off on CFDA Approves Clinical Trials for Novel China AIDS Treatment, Azi Fu (Azvudine)
May 282013
 

Links

http://newdrugapprovals.wordpress.com/2013/05/28/cfda-approves-clinical-trials-for-novel-china-aids-treatment-azi-fu-azvudine/

Share

China’s Curative Medical to Seek CFDA Approval for ALung’s Respiratory Device

 china, Uncategorized  Comments Off on China’s Curative Medical to Seek CFDA Approval for ALung’s Respiratory Device
May 272013
 

 

Links

read all at

http://newdrugapprovals.wordpress.com/2013/05/27/chinas-curative-medical-to-seek-cfda-approval-for-alungs-respiratory-device/

Share

AbbVie and Eisai Announce HUMIRA® Pre-filled Syringe Has Received Approval for the Treatment of Intestinal Behçet’s Disease in Japan

 Uncategorized  Comments Off on AbbVie and Eisai Announce HUMIRA® Pre-filled Syringe Has Received Approval for the Treatment of Intestinal Behçet’s Disease in Japan
May 272013
 

Links

 

read all at

http://newdrugapprovals.wordpress.com/2013/05/27/abbvie-and-eisai-announce-humira-pre-filled-syringe-has-received-approval-for-the-treatment-of-intestinal-behcets-disease-in-japan/

Share
 Older Entries  Newer Entries
Follow

Get every new post on this blog delivered to your Inbox.

Join other followers: